세계의 원격약국(Telepharmacy) 시장 : 성장, 전망, 경쟁 분석(2024-2032년)

The telepharmacy market is expected to grow at a CAGR of 10.5% during the forecast period of 2024 to 2032. Telepharmacy, a segment of telehealth, leverages telecommunications technology to provide pharmaceutical services from a distance. It is especially beneficial in underserved areas where access to pharmacists and healthcare facilities is limited. The market for telepharmacy has seen significant growth due to technological advancements, regulatory changes, and evolving healthcare models that emphasize cost-effectiveness and patient satisfaction.

Drivers

Expansion in Rural and Underserved Areas

Telepharmacy has become a critical solution for delivering pharmaceutical care in rural and underserved regions, where the scarcity of healthcare facilities can impede access to care. By enabling remote dispensing, counseling, and monitoring of medication, telepharmacy bridges the gap in these areas, improving accessibility. For instance, states like North Dakota have pioneered the adoption of telepharmacy to combat pharmacy deserts, leading to an increase in the number of pharmacies serving remote populations without direct access to a local pharmacist. This expansion is supported by changes in state regulations that have allowed more flexible operation models for telepharmacies, further aiding in their proliferation and the improvement of healthcare outcomes in isolated regions.

Technological Advancements

The integration of high-speed internet and secure, user-friendly platforms has propelled the telepharmacy market forward. Advanced software solutions now offer robust platforms for video consultations, prescription management, and patient data privacy, enhancing the efficiency and safety of telepharmacy services. These technologies facilitate real-time communication between patients and pharmacists, ensuring accurate medication dispensing and adherence to treatment plans. Moreover, the advent of AI and machine learning has begun to play a role in streamlining operations and predicting patient medication needs, leading to personalized care and improved patient outcomes.

Cost-Effectiveness and Operational Efficiency

Telepharmacy presents a cost-effective solution for both healthcare providers and patients. It reduces the need for physical infrastructure and staffing, lowering operational costs for pharmacy services. For patients, it minimizes travel time and expenses, particularly in rural areas, thereby increasing the affordability of healthcare. The operational efficiency of telepharmacy also enhances medication management, reducing errors and improving compliance with therapy regimens. This efficiency not only boosts patient health outcomes but also decreases the overall healthcare expenditure by mitigating complications related to poor medication adherence.

Restraint

Regulatory and Legal Challenges

Despite the growth of telepharmacy, it faces significant regulatory and legal challenges that restrain its wider adoption. The variability in pharmacy laws across different jurisdictions can complicate the deployment of telepharmacy services. For example, some states have stringent regulations regarding the physical presence of a pharmacist when dispensing medications, which can limit the implementation of fully remote telepharmacy services. These legal hurdles not only impede the expansion of telepharmacy operations but also create uncertainty for providers, potentially slowing the adoption of telepharmacy innovations and impacting the scalability of services across state lines.

Market Segmentation by Software & Services

The telepharmacy market is segmented into software and services, both integral to the industry's operation and growth. Software in telepharmacy includes platforms that manage patient data, streamline pharmacy operations, and ensure compliance with healthcare regulations. This segment is crucial for the operation of telepharmacy networks, offering tools for medication management, patient counseling, and regulatory documentation. The services segment, on the other hand, includes the provision of remote pharmaceutical services, patient counseling, and administrative support, which are critical for the practical application of telepharmacy. Both segments have demonstrated substantial growth, but the software segment is poised to exhibit the highest CAGR owing to the increasing demand for integrated solutions that offer enhanced security and efficiency in managing remote pharmaceutical services. However, in terms of revenue, services hold the largest share due to the ongoing need for specialized pharmaceutical care and consultation, which often requires more personalized and labor-intensive inputs. This demand for services is driven by the complexity of pharmaceutical consultations and the regulatory requirements for continuous oversight and management in dispensing medications. The growth in the software segment is fueled by advancements in technology and the increasing adoption of digital health solutions across healthcare settings, which streamline operations and reduce costs. Conversely, the revenue dominance in services is bolstered by the high value placed on professional expertise and personalized patient care, which are less easily automated and require ongoing human intervention.

Market Segmentation by End Use

In the telepharmacy market, segmentation by end use includes hospital pharmacies, retail pharmacies, and other end users such as long-term care facilities and outpatient clinics. Hospital pharmacies and retail pharmacies are the primary settings where telepharmacy services are implemented. Hospital pharmacies are increasingly adopting telepharmacy to extend their reach and improve medication management, especially in remote areas or for hospitals with limited on-site pharmacy staff. This segment has shown the highest revenue generation in the market due to the large volume of prescriptions processed and the critical nature of hospital-based pharmaceutical services, which require rigorous oversight and integration with broader hospital treatment plans. Retail pharmacies also significantly contribute to market revenue by offering telepharmacy services that cater to routine prescription needs, over-the-counter consultations, and chronic disease management. Although hospital pharmacies currently dominate in terms of revenue, retail pharmacies are expected to register the highest CAGR. This growth is driven by the expanding scope of services they offer, including direct-to-consumer telehealth services that increase accessibility and convenience for patients. The shift towards more consumer-centered healthcare, along with technological advancements in telepharmacy, are key factors that support the rapid expansion of telepharmacy services in retail settings, highlighting a trend towards more decentralized and patient-oriented pharmaceutical care.

Geographic Trends

The telepharmacy market exhibits varied geographic trends with significant growth across multiple regions. North America currently holds the largest revenue share, attributed to its well-established healthcare infrastructure and early adoption of telehealth technologies. The U.S. in particular has seen widespread implementation of telepharmacy, driven by rural healthcare needs and supported by favorable regulatory frameworks. However, the Asia Pacific region is expected to register the highest Compound Annual Growth Rate (CAGR) from 2024 to 2032. This surge is fueled by increasing healthcare expenditures and rapidly evolving healthcare infrastructures in countries such as China and India, where there is a growing emphasis on healthcare accessibility and digital health solutions. These factors, combined with a large patient base and increasing internet penetration, are propelling the demand for telepharmacy services in the Asia Pacific, making it a dynamic and fast-growing segment of the global market.

Competitive Trends

Competitive trends in the telepharmacy market are shaped by the strategies of key players such as AZOVA, Cardinal Health, CarepathRx, CPS Solutions, Indispensable Health, Infinipharm, Medication Review, OSP, Outcomes, PipelineRx, Right ePharmacy, and Zane Networks. These companies are heavily investing in technology to enhance their service offerings, focusing on expanding their geographic reach and integrating advanced analytics to improve service delivery and patient outcomes. For instance, in 2022, Cardinal Health reported robust revenue growth from its telepharmacy solutions, attributing it to increased demand for remote healthcare services. Similarly, PipelineRx and CarepathRx have been pivotal in advancing cloud-based platforms to facilitate medication management and adherence. Strategic partnerships and acquisitions are also prevalent among these players as they seek to leverage complementary strengths and broaden their market presence. For example, Right ePharmacy has expanded its services across Africa, focusing on remote areas to maximize impact. Looking forward to 2024 to 2032, these companies are expected to intensify their focus on innovative telepharmacy solutions that cater to the evolving needs of a global patient base, with strategic expansions and technological enhancements being key to their growth strategies. These efforts are anticipated to not only increase their service capabilities but also enable them to tap into new markets, driving the overall growth of the telepharmacy industry.

Historical & Forecast Period

This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Telepharmacy market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Telepharmacy market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

• Market Segmentation
• Software & Services

• Software

• On-premises

• Web-based/ cloud-based

• Services

• Remote dispensing

• Remote patient counseling

• Remote order-entry review

• Drug therapy monitoring

• Other services
• End Use

• Hospitals pharmacies

• Retail pharmacies

• Other end users
• Region Segment (2022-2032; US$ Million)
• North America
• U.S.
• Canada
• Rest of North America
• UK and European Union
• UK
• Germany
• Spain
• Italy
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East and Africa
• GCC
• Africa
• Rest of Middle East and Africa

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Telepharmacy market?
• What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Telepharmacy market?
• Which is the largest regional market for Telepharmacy market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Telepharmacy market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Telepharmacy market worldwide?

Table of Contents

1. Preface

• 1.1. Report Description
  • 1.1.1. Purpose of the Report
  • 1.1.2. Target Audience
  • 1.1.3. Key Offerings
• 1.2. Market Segmentation
• 1.3. Research Methodology
  • 1.3.1. Phase I - Secondary Research
  • 1.3.2. Phase II - Primary Research
  • 1.3.3. Phase III - Expert Panel Review
  • 1.3.4. Assumptions
  • 1.3.5. Approach Adopted

2. Executive Summary

• 2.1. Market Snapshot: Global Telepharmacy Market
• 2.2. Global Telepharmacy Market, By Software & Services, 2023 (US$ Million)
• 2.3. Global Telepharmacy Market, By End Use, 2023 (US$ Million)
• 2.4. Global Telepharmacy Market, By Geography, 2023 (US$ Million)
• 2.5. Attractive Investment Proposition by Geography, 2023

3. Telepharmacy Market: Competitive Analysis

• 3.1. Market Positioning of Key Telepharmacy Market Vendors
• 3.2. Strategies Adopted by Telepharmacy Market Vendors
• 3.3. Key Industry Strategies

4. Telepharmacy Market: Macro Analysis & Market Dynamics

• 4.1. Introduction
• 4.2. Global Telepharmacy Market Value, 2022 - 2032, (US$ Million)
• 4.3. Market Dynamics
  • 4.3.1. Market Drivers
  • 4.3.2. Market Restraints
  • 4.3.3. Key Challenges
  • 4.3.4. Key Opportunities
• 4.4. Impact Analysis of Drivers and Restraints
• 4.5. See-Saw Analysis
• 4.6. Porter's Five Force Model
  • 4.6.1. Supplier Power
  • 4.6.2. Buyer Power
  • 4.6.3. Threat Of Substitutes
  • 4.6.4. Threat Of New Entrants
  • 4.6.5. Competitive Rivalry
• 4.7. PESTEL Analysis
  • 4.7.1. Political Landscape
  • 4.7.2. Economic Landscape
  • 4.7.3. Technology Landscape
  • 4.7.4. Legal Landscape
  • 4.7.5. Social Landscape

5. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)

• 5.1. Market Overview
• 5.2. Growth & Revenue Analysis: 2023 Versus 2032
• 5.3. Market Segmentation
  • 5.3.1. Software
    • 5.3.1.1. On-premises
    • 5.3.1.2. Web-based/ cloud-based
  • 5.3.2. Services
    • 5.3.2.1. Remote dispensing
    • 5.3.2.2. Remote patient counseling
    • 5.3.2.3. Remote order-entry review
    • 5.3.2.4. Drug therapy monitoring
    • 5.3.2.5. Other services

6. Telepharmacy Market: By End Use, 2022-2032, USD (Million)

• 6.1. Market Overview
• 6.2. Growth & Revenue Analysis: 2023 Versus 2032
• 6.3. Market Segmentation
  • 6.3.1. Hospitals pharmacies
  • 6.3.2. Retail pharmacies
  • 6.3.3. Other end users

7. North America Telepharmacy Market, 2022-2032, USD (Million)

• 7.1. Market Overview
• 7.2. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
• 7.3. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
• 7.4.Telepharmacy Market: By Region, 2022-2032, USD (Million)
  • 7.4.1.North America
    • 7.4.1.1. U.S.
      • 7.4.1.1.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 7.4.1.1.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 7.4.1.2. Canada
      • 7.4.1.2.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 7.4.1.2.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 7.4.1.3. Rest of North America
      • 7.4.1.3.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 7.4.1.3.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)

8. UK and European Union Telepharmacy Market, 2022-2032, USD (Million)

• 8.1. Market Overview
• 8.2. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
• 8.3. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
• 8.4.Telepharmacy Market: By Region, 2022-2032, USD (Million)
  • 8.4.1.UK and European Union
    • 8.4.1.1. UK
      • 8.4.1.1.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 8.4.1.1.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 8.4.1.2. Germany
      • 8.4.1.2.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 8.4.1.2.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 8.4.1.3. Spain
      • 8.4.1.3.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 8.4.1.3.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 8.4.1.4. Italy
      • 8.4.1.4.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 8.4.1.4.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 8.4.1.5. France
      • 8.4.1.5.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 8.4.1.5.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 8.4.1.6. Rest of Europe
      • 8.4.1.6.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 8.4.1.6.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)

9. Asia Pacific Telepharmacy Market, 2022-2032, USD (Million)

• 9.1. Market Overview
• 9.2. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
• 9.3. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
• 9.4.Telepharmacy Market: By Region, 2022-2032, USD (Million)
  • 9.4.1.Asia Pacific
    • 9.4.1.1. China
      • 9.4.1.1.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 9.4.1.1.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 9.4.1.2. Japan
      • 9.4.1.2.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 9.4.1.2.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 9.4.1.3. India
      • 9.4.1.3.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 9.4.1.3.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 9.4.1.4. Australia
      • 9.4.1.4.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 9.4.1.4.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 9.4.1.5. South Korea
      • 9.4.1.5.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 9.4.1.5.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 9.4.1.6. Rest of Asia Pacific
      • 9.4.1.6.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 9.4.1.6.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)

10. Latin America Telepharmacy Market, 2022-2032, USD (Million)

• 10.1. Market Overview
• 10.2. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
• 10.3. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
• 10.4.Telepharmacy Market: By Region, 2022-2032, USD (Million)
  • 10.4.1.Latin America
    • 10.4.1.1. Brazil
      • 10.4.1.1.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 10.4.1.1.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 10.4.1.2. Mexico
      • 10.4.1.2.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 10.4.1.2.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 10.4.1.3. Rest of Latin America
      • 10.4.1.3.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 10.4.1.3.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)

11. Middle East and Africa Telepharmacy Market, 2022-2032, USD (Million)

• 11.1. Market Overview
• 11.2. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
• 11.3. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
• 11.4.Telepharmacy Market: By Region, 2022-2032, USD (Million)
  • 11.4.1.Middle East and Africa
    • 11.4.1.1. GCC
      • 11.4.1.1.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 11.4.1.1.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 11.4.1.2. Africa
      • 11.4.1.2.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 11.4.1.2.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)
    • 11.4.1.3. Rest of Middle East and Africa
      • 11.4.1.3.1. Telepharmacy Market: By Software & Services, 2022-2032, USD (Million)
      • 11.4.1.3.2. Telepharmacy Market: By End Use, 2022-2032, USD (Million)

12. Company Profile

• 12.1. AZOVA
  • 12.1.1. Company Overview
  • 12.1.2. Financial Performance
  • 12.1.3. Product Portfolio
  • 12.1.4. Strategic Initiatives
• 12.2. Cardinal Health
  • 12.2.1. Company Overview
  • 12.2.2. Financial Performance
  • 12.2.3. Product Portfolio
  • 12.2.4. Strategic Initiatives
• 12.3. CarepathRx
  • 12.3.1. Company Overview
  • 12.3.2. Financial Performance
  • 12.3.3. Product Portfolio
  • 12.3.4. Strategic Initiatives
• 12.4. CPS Solutions
  • 12.4.1. Company Overview
  • 12.4.2. Financial Performance
  • 12.4.3. Product Portfolio
  • 12.4.4. Strategic Initiatives
• 12.5. Indispensable Health
  • 12.5.1. Company Overview
  • 12.5.2. Financial Performance
  • 12.5.3. Product Portfolio
  • 12.5.4. Strategic Initiatives
• 12.6. Infinipharm
  • 12.6.1. Company Overview
  • 12.6.2. Financial Performance
  • 12.6.3. Product Portfolio
  • 12.6.4. Strategic Initiatives
• 12.7. Medication Review
  • 12.7.1. Company Overview
  • 12.7.2. Financial Performance
  • 12.7.3. Product Portfolio
  • 12.7.4. Strategic Initiatives
• 12.8. OSP
  • 12.8.1. Company Overview
  • 12.8.2. Financial Performance
  • 12.8.3. Product Portfolio
  • 12.8.4. Strategic Initiatives
• 12.9. Outcomes
  • 12.9.1. Company Overview
  • 12.9.2. Financial Performance
  • 12.9.3. Product Portfolio
  • 12.9.4. Strategic Initiatives
• 12.10. PipelineRx
  • 12.10.1. Company Overview
  • 12.10.2. Financial Performance
  • 12.10.3. Product Portfolio
  • 12.10.4. Strategic Initiatives
• 12.11. Right ePharmacy
  • 12.11.1. Company Overview
  • 12.11.2. Financial Performance
  • 12.11.3. Product Portfolio
  • 12.11.4. Strategic Initiatives
• 12.12. Zane Networks
  • 12.12.1. Company Overview
  • 12.12.2. Financial Performance
  • 12.12.3. Product Portfolio
  • 12.12.4. Strategic Initiatives
• 12.13. Other Notable Players
  • 12.13.1. Company Overview
  • 12.13.2. Financial Performance
  • 12.13.3. Product Portfolio
  • 12.13.4. Strategic Initiatives